Concentrations of trace minerals in the spinal cord of horses with equine motor neuron disease

American Journal of Veterinary Research

Volumn 61, Issue 6, 2000, Pages 609-611

  Polack, Evelyne W ^a,b   King, John M ^a   Cummings, John F ^a   Mohammed, Hussni O ^a   Birch, Milton ^a,c   Cronin, Thomas ^a,d  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c Bucks Laboratories   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE;

ALUMINUM; CADMIUM; CALCIUM; CHROMIUM; COPPER; IRON; LEAD; MAGNESIUM; MANGANESE; MERCURY; PHOSPHORUS; POTASSIUM; SELENIUM; SODIUM; TRACE ELEMENT; ZINC;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMISTRY; FEMALE; HORSE; HORSE DISEASE; MALE; MOTOR NEURON DISEASE; SPINAL CORD; SPINAL CORD DISEASE;

ALUMINUM; ANIMALS; CADMIUM; CALCIUM; CHROMIUM; COPPER; FEMALE; HORSE DISEASES; HORSES; IRON; LEAD; MAGNESIUM; MALE; MANGANESE; MERCURY; MOTOR NEURON DISEASE; PHOSPHORUS; POTASSIUM; SELENIUM; SODIUM; SPINAL CORD; SPINAL CORD DISEASES; TRACE ELEMENTS; ZINC;

EID: 0034203738     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.609     Document Type: Article

References (39)

1. Cummings JF, de Lahunta A, George C, et al. Equine motor neuron disease; a preliminary report. Cornell Vet 1990;80: 357-379.
2. Swash M, Schwartz MS. What do you really know about amyotrophic lateral sclerosis? J Neurol Sci 1992;113:4-16.
3. Sustronck B, Deprez P, Van Roy M, et al. Equine motor neuron disease: the first confirmed case in Europe. Vlaams Diergeneeskd Tijdschr 1993;62:40-44.
4. Kuwamura M, Iwaki M, Yamate J, et al. The first case of equine motor neuron disease in Japan. J Vet Med Sci 1994;56:195-197.
5. Divers TJ, Mohammed HO, Cummings JF, et al. Equine motor neuron disease: a new cause of weakness, trembling, and weight loss. Compend Contin Educ Pract Vet 1992;14:1222-1226.
6. Divers TJ, Mohammed, HO, Cummings JF, et al. Equine motor neuron disease: findings in 28 horses and proposal of a pathophysiological mechanism for the disease. Equine Vet J 1994;26: 409-415.
7. Mohammed HO, Cummings JF, Divers TJ, et al. Risk factors associated with equine motor neuron disease. A possible model for human motor neuron disease. Neurology 1993;43:966-971.
8. Amorin RM, Kuchembuck MRG, Gonçalves RC, et al. Doença do neurônio motor dos eqüinos: relato dos primeiros casos na America do Sul. Braz J Vet Res Anim Sci 1996;33:47-52.
9. Deng HX, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 1993;261:1047-1051.
10. Sillevis Smitt PAE, de Jong JMBV. Animal models of amyotrophic lateral sclerosis and spinal cord muscular atrophies. J Neurol Sci 1989;91:231-258.
11. Bradley WG, Krasin F. A new hypothesis of the etiology of amyotrophic lateral sclerosis: the DNA hypothesis. Arch Neurol 1982;39:677-680.
12. Aran FA. Recherches sur une maladie non encore decrite du systeme musculaire (atrophic musculaire progressive). Arch Gen Med 1850;24:172-214.
13. Williams DB, Windebank AJ. Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clin Proc 1991;66:54-82.
14. Kilness AW, Hochberg FH. Amyotrophic lateral sclerosis in a high selenium environment. JAMA 1977;237:2843-2844.
15. Mitchell JD, East BW, Harris IA, et al. Trace elements in the spinal cord and other tissues in motor neuron disease. J Neurol Neurosurg Psychiatry 1986;48:211-215.
16. Nagata HS, Miyata S, Nakamura S, et al. Heavy metal concentration in blood cells in patients with amyotrophic lateral sclerosis. J Neurol Sci 1985;67:173-178.
17. Norris FH Jr, U KS. Amyotrophic lateral sclerosis and low urinary selenium levels. JAMA 1978;239:404.
18. Pierce-Ruhland R, Patten BM. Muscle metals in motor neuron disease. Ann Neurol 1980;8:193-195.
19. Mitchell JD, Harris LA, East BW, et al. Trace elements in cerebrospinal fluid in motor neuron disease. Br Med J 1984;288:1791-1792.
20. Yase Y. Environmental contribution to the amyotrophic lateral sclerosis. In: Serratice G, Cross D, Desnuelle C, et al, eds. Neuromuscular diseases. New York: Raven Press, 1984;335-339.
21. Ywata S. Structural analysis of metal coprecipitated calcification products in the central nervous system with particular reference to amyotrophic lateral sclerosis. Neurol Med (Tokyo) 1980;13:103-107.
22. Yoshimasu F, Masaiuki Y, Yase Y, et al. Studies on amyotrophic lateral sclerosis by neutron activation analysis-2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer disease cases. Folia Psychiatr Neurol Japan 1980;34:75-82.
23. Yanagihara R. Heavy metals and essential minerals in motor neuron disease. In: Rowland LP, ed. Human motor neuron diseases. New York: Raven Press, 1982;36:233-247.
24. Mitchell JD. Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin 1987;5:43-60.
25. Moody JR, Lindstron RM. Selection and cleaning of plastic containers for storage of trace elements samples. Anal Chem 1977;49:2264.
26. Helrich K. Official methods of analysis of the Association of Official Analytical Chemists, vol 1. Arlington: Association of Official Analytical Chemists, 1990;42.
27. Yeager DW, Cholack J, Henderson EW. Determination of lead in biological and related material by atomic absorption spectrophotometry. J Environ Sci Tech 1971;5:1020-1022.
28. Munns RK, Holland DC. Determination of mercury in fish by flameless atomic absorption: a collaborative study. J Assoc Off Anal Chem 1971;54:202-205.
29. Whetter PA, Ullrey DE. Improved fluorometric method for determining selenium. J Assoc Off Anal Chem 1978;61:927-930.
30. Goyer RA. Toxic effects of metals. In: Amdur MO, Doull J, Klaassen CD, eds. Toxicology. The basic science of poisons. New York: Pergamon Press, 1991;623-680.
31. Smith RM, Dreosti IE. Neurobiology of trace elements. Vol I. Clifton: The Human Press, 1983.
32. Halliwell B, Gutteridge JMC. The importance of free radicals and catalytic metal ions in human disease. Mol Aspects Med 1985;8:89-193.
33. Hanna PM, Mason RP. Direct evidence for inhibition of free radical formation from Cu(I) and hydrogen peroxide by glutathione and other potential ligands using the EPR spin-trapping technique. Arch Biochem Biophys 1992;295:205-213.
34. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1994;38:357-366.
35. Fong KL, McCay PB, Poyer JL, et al. Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. J Biol Chem 1973;248:7792-7796.
36. Slater TF. Free radical mechanisms in tissue injury. Biochem J 1984;222:1-15.
37. Dill SG, Hintz HF, de Lahunta A, et al. Plasma and liver copper values in horses with equine degenerative myeloencephalopathy. Can J Vet Res 1989;53:29-32.
38. Blythe LL, Craig AM, Rowe KE, et al. Serially determined plasma alpha tocopherol concentrations and results of the oral vitamin E absorption test in clinically normal horses and in horses with degenerative myelopathy. Am J Vet Res 1991;52:908-911.
39. Mayhew IG, Stowe HD, Trapp AL, et al. Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial. J Vet Intern Med 1987;1:45-49.